Brain Hypoxia clinical trials at UCLA
2 in progress, 1 open to eligible people
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
open to eligible people ages up to 17 years
This is a multicenter trial to establish the efficacy of cooling and the optimal duration of induced hypothermia for neuroprotection in pediatric comatose survivors of cardiac arrest. The study team hypothesizes that longer durations of cooling may improve either the proportion of children that attain a good neurobehavioral recovery or may result in better recovery among the proportion already categorized as having a good outcome.
Los Angeles, California and other locations
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
Sorry, in progress, not accepting new patients
A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.
Los Angeles, California and other locations
Our lead scientists for Brain Hypoxia research studies include Micah B. Kadden, MD Richelle J. Cooper, MD.
Last updated: